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Somatostatin(SST) is a 14-or 28-amino acid peptide that was originally described in 1973 as a hypothalamic NE hormone (1), whose role was to inhibit the secretion of growth hormone from the anterior pituitary gland. The presence ofthis peptide hormone was subsequently detected throughout the central and peripheral nervous systems, in the endocrine pancreas and in the gut, and to a lower extent in the thyroid, adrenals and submandibular glands, kidney, liver, colon, rectum, small intestine, stomach, placenta, and prostate.
SST is known to inhibit the secretion of a wide range of hormones, exocrine glands, and gastrointestinal motility. Among other findings is the inhibition of immunoglobulin synthesis and lymphocyte proliferation in lymphoid tissues. SST has revealed an antiproliferative potential, reversing the impact of mitogenic signals delivered by substances such as epidermal growth factor and somatomedin C/insulin-like growth factor-l (2). SST has been found to play a critical role in the negative control of cell growth and to act as a tumor suppressor gene for pancreatic cancer and medullary thyroid carcinoma (3).
The actions of SST are mediated by a family of transmembrane domain G-protein-coupled receptors that comprise five distinct subtypes (termed SSTRI to 5). SSTRs are widely expressed in many organs, including the central nervous system (4), gastrointestinal tract (5) , pancreas (6) , kidney (7) , prostate (8) (9) . Frequently, multiple subtypes coexist in the same cell. The five SSTRs share common signaling pathways such as the inhibition ofadenylate cyclase, activation of phosphotyrosine phosphatase, and modulation of mitogen-activated protein kinase through G-protein-dependent mechanisms (3).
Cloning offive SSTRs has led to the development of subtype-selective agonists. Among those, SSTR2-specific SST analogues octreotide (OCT) and lanreotide have attracted significant attention for several years. They have been used as new diagnostic and treatment modalities for various endocrine disorders and as adjunctive treatment for a variety of benign and malignant tumours (10) (11) . The antiproliferative and antiangiogenic properties of OCT have been exploited in several clinical trials (12) . It is therefore very important to determine cell expression and localization of the five SSTRs in prostate lesions. In particular, somatostatin receptor profiling in individual patients may be of relevance to better tailor the somatostatin analogue-based treatment. The feasibility of detecting immunohistochemically the five SSTRs was investigated by our group in a preliminary study on the normal prostate tissue obtained from patients with clinical diagnosis of benign prostatic hyperplasia (13) .
In a previous study from our group (14) , the five SSTRs were immunohistochemically evaluated in PCa as well as in HGPIN and Nep in RPs with hormone dependent incidental and clinical cancers. It was found that the subtype 1 was mostly seen in the basal cells of Nep and in the smooth muscle and endothelial cells; the secretory cells in Nep expressed the subtype 3, whereas the subtype 4 was present in HGPIN and PCa. The study showed some differences in the expression and localization of SSTRs between normal and neoplastic tissue, and further defined the differences between insignificantand significant cancers (15) (16) (17) (18) .
Almost all prostate cancers have focal NE differentiation,although the majority show only rare or sparse single NE cells, as demonstrated by NE markers. In 5-10% ofprostatic carcinomas there are zones with a large number ofsingle or clustered NE cells detected by Chromogranin A immunostaining. Scant information is available on SSTR subtype expression and localization in PCa with NE differentiation, in comparison to conventional PCa (19) . The aim of the current study is to examine immunohistochemically the expression and localization of the five SSTRs in PCa with NE differentiation.
MATERIALS AND METHODS
Sixty radical prostatectomy specimens were obtained from the Pathology Services associated with the United Hospitals-Polytechnic University of the Marche Region. The specimens represented three groups ofpatients whose characteristics are in Table I .
Twenty RPs with pT2a and Gleason score 3+3=6 acinar PCa (name given to this group: RP 3, where 3 indicates that the Gleason pattern 3 was analyzed). This group was included in a previous study (20) .
Twenty RPs with pT2a and Gleason score 4+4=8 and 4+5=9 acinar PCa (See Table I The patients in the three groups of RPs were hormonally untreated. The whole-mount technique with complete sampling was used to process the RPs, examined histologically as 5 urn-thick whole-mount haematoxylin and eosin (H&E) stained sections. The most representative blocks containing compartments ofNep, HGPIN and PCa were selected. The RP samples were all from the peripheral zone ofthe prostate to avoid that the evaluations ofthe five SSTRs were influenced by their zonal distribution. PCa in the RP NE group was characterised by a conventional acinar PCa with zones with a large number of single or clustered NE cells detected by Chromogranin A immunostaining. The NE component occupied between 10% to 30% of the neoplasms.
Immunohistochemical staining Antibody against somatostatin receptor subtypes
For immunohistochemistry, all rabbit polyclonal anti-SSTR subtype antibodies were commercially obtained from Chemicon® International Inc. (Temecula, CA, USA). Dilution of the antibodies used is shown in Table  II . Positive control experiments included normal human pancreas and/or anterior pituitary gland obtained from surgery and autopsy, respectively. Negative controls were used for the tested antibodies; the primary antibody was replaced by rabbit non-immune serum.
Immunohistochemistry
Ten percent formalin-fixed, paraffin-embedded tissue blocks were serially cut into 5 urn thick sections which were mounted on silane-coated slides. The sections were then dewaxed in xylene and rehydrated through a graded series of ethanol. Antigen retrieval was done by microwave treatment for 20 min at 98°C using 0.01 M Citric Acid buffer pH 6.0. Endogenous peroxidase activity was quenched by incubating the sections in 3% hydrogen peroxide for 10 min at room temperature. Non-specific binding sites were blocked through pre-incubation with 1% albumin bovine in PBS for 20 min at room temperature. Reacted tissue sections were then incubated with the antibodies for each SSTR subtype for 18 h at 4°C. Antigen-antibody complex was subsequently visualized using the Envision" Detection System kit peroxidase/DAB (DAKO, Glustrop, Denmark) and counterstained with haematoxylin.
Evaluation ofimmunohistochemistry and statistics
At least 1,000 cells were counted in contiguous 400X microscopic fields in each case, separately for secretory epithelium, basal cells when identifiable,smooth muscle cells of the stroma and endothelial cells ( Fig. 1 ). Nep and HGPIN areas were 5 mm away from PCa, whereas smooth muscle and endothelial cells were measured in areas approximately 1 mm away from PCa. Immunostaining was evaluated for the following three cell components: cytoplasm, membrane and nucleus. Staining intensity was graded as 1+, 2+ and 3+. In each case the percentages of positive cells and of cells with strong intensity (i.e., 2+ and 3+) were evaluated. For each group the mean and standard deviation were then calculated. The differences between groups were considered statistically significant at a value ofp<0.05 (Mann-Whitney test, SPSS software, SPSS Inc., Chicago, Illinois).
Assessment ofantibody specificity
In order to evaluate the specificity of the five rabbit polyclonal anti-SSTR antibodies employed in this study, we performed western blot (WB) experiments on a prostate tissue extract. Briefly, a prostate tissue sample was homogenized at 10% (wt/vol) in Tris-buffered saline (TBS; 0.05 M Tris/O.2 M NaCI, pH 7.4) containing 1% Nonidet P-40 and 1% sodium deoxycholate (DOC). Homogenate was clarified at 500 g for 15 min at 4°C. Protein concentration in the supernatant was determined by Bio-Rad protein assay. Six individual 100 ug aliquots of prostate homogenate were mixed with Laemmli buffer, heated to 100°C for 10 min, then run on a 10% SDSIPAGE gel and transferred onto a nitrocellulose membrane. The membrane was blocked with 5% (wt/vol) non-fat dry milk in TBS containing 0.1% Tween 20 (TBST) for 1 h at room temperature, then cut in six vertical parts separated by colour molecular markers. Each individual membrane was then independently probed overnight at 4°C with one of the five anti-SSTR reagents at a concentration of 2.5 ug/ml in TBS; the sixth membrane was incubated with non immune rabbit IgG (Santa Cruz Biotechnology, Heidelberg, Germany) at the same concentration. After five washes in TBST, membranes were incubated for 45 min at room temperature with horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology, Heidelberg, Germany) diluted 1:5,000 in TBS. Membranes were then washed five times in TBST and visualized with enhanced chemiluminescence reagent (Pierce) by Chemi-Doc (Bio-Rad Laboratories, Hercules, CA, USA) analysis system. WB analysis of prostate tissue performed with the panel of five polyclonal anti-SSTR antibodies yielded single bands as previously described by Helboe et al. (21) (further data not shown).
RESULTS

Epithelial secretory cells in normal-looking epithelium, HGPIN and PCa Cytoplasmic staining
The mean percentages of positive cells in Nep, HGPIN and PCa for the five subtypes were similar, with no statistically significant differences between the three RP groups (Table III) . The mean proportions of cells with strong cytoplasmic staining in HGPIN were intermediate between Nep and PCa. The differences were statistically significant, mainly between Nep and PCa, for some of the comparisons (for instance, for the subtype 4, PCa with NE differentiation vs.Nep and vs. HGPIN in the RP NE group: p = 0.016 and p = 0.012, respectively). The greatest mean values in PCa were seen for the subtypes 2, mainly in the group of RP with NE differentiation, and for the subtype 4 in all three groups ( Fig. 2A ).
Cell membrane staining
Membrane staining was seen with the subtypes 3 and 4. The mean percentages ofpositive cells, higher in the subtype 3 than in the subtype 4, decreased from Nep to HGPIN and PCa in all three RP groups (Fig. 28 ). In the latter two, the mean percentages were similar. For subtype 3 but not for subtype 4, the differences between Nep and HGPIN and PCa were statistically significant for the three RP groups (p < 0.001). For PCa there were no statistically significant differences between the three RP groups. A small percentage of cells with strong staining was seen with subtype 3 in Nep in all three RP groups (mean proportions: 13.8% in RP 3; 12.8% in RP 4/5 and 11.5% in RP NE).
Nuclear staining
Nuclear staining was seen with subtypes 4 and 5. For subtype 4, the mean percentages in the PCa of the three groups were higher than in HGPIN and Nep, the highest proportion being with PCa with NE differentiation (PCa with NE differentiation vs. Nep: p = 0.002; PCa with NE differentiation vs. HGPIN: p < 0.001). There were also some statistically significant differences between PCa with NE differentiation and PCa in the RP 3 and RP 4/5 groups (p< 0.002 and p = 0.004), but not between the latter two. For the subtype 5, the mean percentages in Nep were greater than in HGPIN and PCa (Fig. 2C ), some of the differences being statistically significant (for instance in the RP NE group, PCa vs Nep: p = 0.007; HGPIN vs Nep: p = 0.035). There were very few nuclei with strong staining intensity in the PCa in the RP 4/5 and RP NE groups (mean proportions: 0.3% and 1.0%, respectively).
Additional information
SSTR subtype expression and localization in the cancer areas in the RP 4/5 were slightly greater than in the RP 3 (Table III) , the differences being not statistically significant. There were no differences between Gleason 4 and 5 areas. SSTR subtype expression and localization in the cancer areas adjacent to the NE component were similar to those seen in RP 3 and RP 4/5. Individual cells in Nep, HGPIN and PCa (other than the NE component) in the three RP groups showed SSTR subtype expression and localization similar to that seen in the cancer areas with NE differentiation (Fig. 1A) . The cells in the same location proved to be Chromogranin A positive in adjacent sections.
Basal cells in normal-looking epithelium and HGPIN
Immunoreactivity was primarily detected in the cytoplasm. The mean proportions in Nep were greater than in HGPIN. In Nep the mean proportions of cells with strong staining intensity were greater for subtypes 1 and 3 than for the other subtypes, the lowest being with subtype 2. The differences between pairs of groups in Nep and in HGPIN were not statistically significant. The differences were statistically significant between Nep and HGPIN for several comparisons, in particular for subtype 1 (p < 0.001), subtype 2 (p = 0.005), subtype 4 (p < 0.001) The values in brackets are those with strong intensity, i.e., with 2+ and 3+ (See text for abbreviations) and subtype 5 (p < 0.001) in the RP NE group. In HGPIN the highest mean proportions of positive cells was with the subtype 3, the proportions in the three RP groups being similar (Fig. 3) .
Smooth muscle cells
Positive cells were seen with all the five subtypes, the highest mean values being in the subtype 1 and the lowest in the subtype 5. The subtype 1 showed a strong immunoreactivity in the cytoplasm in more than 50% of the cells, the proportions being similar in the three RP subgroups, the differences being the three RP groups being not statistically significant (Fig. 4A ). Cell membrane staining was not observed. Nuclear staining was seen only with the subtypes 4 and 5, it was always weak and observed in a minority of cells.
Endothelial cells
The pattern of stammg was similar to that seen in the smooth muscle cells, with the highest proportion of positive cells in the subtype 1 and the lowest in the subtype 5. For the former subtype the highest proportion of cells with strong intensity was seen with the RP NE group, the difference being statistically significant between RP NE and RP 3, and between RP NE and RP 4/5 (p<O.OOI in both comparisons) ( Fig. 4B ). There was no cell membrane and nuclear staining.
DISCUSSION
Information on the expression and localization of the five SSTR subtypes in prostate neoplasms has been reported in a small number of studies in which immunohistochemistry, in situ hybridization, and autoradiography have been applied (8-9, 13, 19, 22-24) (Table IV) . It is almost impossible to obtain information on the expression and localization of these five SSTR subtypes when employing molecular methods which treat the tissue as a mass (8, 19, (22) (23) .
A preliminary immunohistochemical study by our group (13) showed the intracellular expression and localization of the five SSTR subtypes in non-neoplastic prostate tissue. Although SSTRs are membrane-associated receptors, a significant amount of staining was seen within the cytoplasm, and some nuclear staining was also present in many immunoreactive cells. The interpretation, based also on molecular studies suggesting nuclear accumulation of SST analogs mediated by SSTRs (II, 25) , was that, after binding their ligand at the cell membrane level, SSTR-ligand complexes undergo cellular internalization with progressive translocation from the cytoplasm to the nucleus where SSTRs exert the effect of somatostatin. The results obtained in the current study confirm the findings of our previous investigation where cell type localization of the five SSTRs was shown in normal-looking prostate tissue, in HGPIN and conventional PCa (14) . In particular, the subtype I was mostly seen in the basal cells ofNep and in the smooth muscle and endothelial cells; the secretory cells in Nep expressed the subtype 3, whereas the subtype 4 was present in HGPIN and PCa. In particular, SSTR subtype expression and localization in the cancer areas in the RP 4/5 were slightly greater than in the RP 3.
The present study greatly expands our knowledge on the expression and localization of the five SSTRs in the epithelial, stromal smooth muscle and blood vessel endothelial cells by investigating PCa with NE differentiation in comparison with conventional PCa. The main findings are represented by the fact that the highest proportions of epithelial cells are seen with the subtypes 2 (cytoplasmic staining) and 4 (cytoplasmic and nuclear staining) in PCa with NE differentiation.
The immunohistochemical expression at the epithelial cell level of the five SSTRs in normal and pathological prostate tissue was also investigated by Dizeyi et al. (19) . They observed the presence of SSTRI and SSTR3 in tumoral and non-tumoral epithelial cells as well as in the stromal compartment, whereas SSTR4 was found to be confined to epithelial cells, and SSTR5 was not detectable. A recent study by Volante el al. (24) with NE differentiation and that SSTR expression significantly correlates with survival.
Our studies have shown that the SSTRs are also expressed in the smooth muscle cells of the prostatic stroma and in the endothelial cells. Concerning the smooth muscle cells , subtype 1 was the most intensely expressed receptor and its location was in the cytoplasm. Subtypes 2, 3 and 4 were also seen in the cytoplasm with their expression being always weak. Close to 80% of the cells were negative for subtype 5. Our findings are similar to those obtained by Reubi et al. (23) in their molecular study ofSSTRI, 
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